See more : GetFugu, Inc. (GFGU) Income Statement Analysis – Financial Results
Complete financial analysis of Deep Medicine Acquisition Corp. (DMAQR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Deep Medicine Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Ion Beam Applications SA (IOBCF) Income Statement Analysis – Financial Results
- San Leon Energy plc (SLE.L) Income Statement Analysis – Financial Results
- Chu Kong Petroleum and Natural Gas Steel Pipe Holdings Limited (1938.HK) Income Statement Analysis – Financial Results
- Healthcare AI Acquisition Corp. (HAIAW) Income Statement Analysis – Financial Results
- Harmonic Drive Systems Inc. (HSYDF) Income Statement Analysis – Financial Results
Deep Medicine Acquisition Corp. (DMAQR)
Industry: Shell Companies
Sector: Financial Services
About Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 20.58M | 20.23M | 21.25M | 0.00 |
| Cost of Revenue | 8.54M | 7.02M | 5.26M | 0.00 |
| Gross Profit | 12.05M | 13.21M | 15.98M | 0.00 |
| Gross Profit Ratio | 58.53% | 65.30% | 75.23% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 11.57M | 8.19M | 0.00 |
| Selling & Marketing | 0.00 | 956.19K | 601.31K | 0.00 |
| SG&A | 20.71M | 2.17M | 409.91K | 59.40K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 20.71M | 2.17M | 409.91K | 59.40K |
| Cost & Expenses | 29.24M | 2.17M | 409.91K | 59.40K |
| Interest Income | 1.62M | 0.00 | ||
| Interest Expense | 0.00 | 0.00 | ||
| Depreciation & Amortization | 58.64K | 226.20K | 187.44K | 0.00 |
| EBITDA | -8.60M | -2.17M | -409.91K | -59.40K |
| EBITDA Ratio | -41.79% | -10.71% | -1.93% | 0.00% |
| Operating Income | -8.66M | -2.17M | -409.91K | -59.40K |
| Operating Income Ratio | -42.07% | -10.71% | -1.93% | 0.00% |
| Total Other Income/Expenses | -1.62M | -1.69M | -118.83K | 5.00 |
| Income Before Tax | -10.28M | -342.66K | -414.05K | -59.40K |
| Income Before Tax Ratio | -49.96% | -1.69% | -1.95% | 0.00% |
| Income Tax Expense | 0.00 | 57.57K | -187.44K | 0.00 |
| Net Income | -10.28M | -400.23K | -414.05K | -59.40K |
| Net Income Ratio | -49.96% | -1.98% | -1.95% | 0.00% |
| EPS | -1.22 | -0.03 | -0.03 | 0.00 |
| EPS Diluted | -1.22 | -0.03 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 8.41M | 13.26M | 16.43M | 16.43M |
| Weighted Avg Shares Out (Dil) | 8.41M | 13.26M | 16.43M | 16.43M |
Source: https://incomestatements.info
Category: Stock Reports